Schmid Michael, Oehme Rainer, Schalasta Gunnar, Brockmann Stefan, Kimmig Peter, Enders Gisela
Institute for Virology, Infectiology and Epidemiology e,V, 70193 Stuttgart, Germany.
BMC Infect Dis. 2004 Jun 9;4:15. doi: 10.1186/1471-2334-4-15.
Noroviruses (NoV) have become one of the most commonly reported causative agents of large outbreaks of non-bacterial acute gastroenteritis worldwide as well as sporadic gastroenteritis in the community. Currently, reverse transcriptase polymerase chain reaction (RT-PCR) assays have been implemented in NoV diagnosis, but improvements that simplify and standardize sample preparation, amplification, and detection will be further needed. The combination of automated sample preparation and real-time PCR offers such refinements.
We have designed a new real-time RT-PCR assay on the LightCycler (LC) with SYBR Green detection and melting curve analysis (Tm) to detect NoV RNA in patient stool samples. The performance of the real-time PCR assay was compared with that obtained in parallel with a commercially available enzyme immunoassay (ELISA) for antigen detection by testing a panel of 52 stool samples. Additionally, in a collaborative study with the Baden-Wuerttemberg State Health office, Stuttgart (Germany) the real-time PCR results were blindly assessed using a previously well-established nested PCR (nPCR) as the reference method, since PCR-based techniques are now considered as the "gold standard" for NoV detection in stool specimens.
Analysis of 52 clinical stool samples by real-time PCR yielded results that were consistent with reference nPCR results, while marked differences between the two PCR-based methods and antigen ELISA were observed. Our results indicate that PCR-based procedures are more sensitive and specific than antigen ELISA for detecting NoV in stool specimens.
The combination of automated sample preparation and real-time PCR provided reliable diagnostic results in less time than conventional RT-PCR assays. These benefits make it a valuable tool for routine laboratory practice especially in terms of rapid and appropriate outbreak-control measures in health-care facilities and other settings.
诺如病毒(NoV)已成为全球非细菌性急性胃肠炎大规模暴发以及社区散发性胃肠炎最常报告的病原体之一。目前,逆转录聚合酶链反应(RT-PCR)检测法已应用于诺如病毒诊断,但仍需要进一步改进以简化和标准化样本制备、扩增及检测过程。自动化样本制备与实时PCR的结合提供了这样的改进。
我们在LightCycler(LC)上设计了一种新的实时RT-PCR检测法,采用SYBR Green检测和熔解曲线分析(Tm)来检测患者粪便样本中的诺如病毒RNA。通过检测一组52份粪便样本,将实时PCR检测法的性能与同时使用的用于抗原检测的市售酶免疫测定(ELISA)的性能进行比较。此外,在与德国斯图加特巴登-符腾堡州卫生办公室的一项合作研究中,由于基于PCR的技术现在被认为是粪便标本中诺如病毒检测的“金标准”,因此使用先前成熟的巢式PCR(nPCR)作为参考方法对实时PCR结果进行盲法评估。
通过实时PCR对52份临床粪便样本进行分析,结果与参考nPCR结果一致,而基于PCR的两种方法与抗原ELISA之间存在显著差异。我们的结果表明,基于PCR的方法在检测粪便标本中的诺如病毒时比抗原ELISA更敏感、更特异。
自动化样本制备与实时PCR相结合,能在比传统RT-PCR检测更短的时间内提供可靠的诊断结果。这些优点使其成为常规实验室实践中的一种有价值的工具,特别是在医疗保健机构和其他场所采取快速且适当的疫情控制措施方面。